On the upside
Thoratec's (Nasdaq: THOR) new generation heart pump HeatMate II improves the survival of heart failure patients.
Although earnings slipped for Sina (Nasdaq: SINA), the results topped estimates and the company forecast upbeat fourth quarter revenue prompting an upgrade.
In a deal valued at approximately $860 million, Omega Healthcare Investors (NYSE: OHI) will purchase the majority of the healthcare net least portfolio of CapitalSource (NYSE: CSE).
On the downside
Analysts downgraded SunPower (Nasdaq: SPWRA) after the company launched an internal investigation into possible accounting errors at its manufacturing facilities in the Philippines.
Isis Pharmaceuticals (Nasdaq: ISIS) and Genzyme (Nasdaq: GENZ) reported that their cholesterol drug met goals of a late stage clinical trial but approval applications will be delayed until mid-2011.
Smith International (NYSE: SII) will raise capital through an offering of 28 million common shares.
In the broad market, declining issues outpaced advancers by a margin of 4 to 3 on both the NYSE and Nasdaq. The Russell 2000 which tracks small cap stocks added a fraction to 603.
